Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Hangzhou Tigermed Consulting logo

Hangzhou Tigermed Consulting

US$38.02

US$58.0b

-5.33%

43.20%

Dashboard Funda..tals Deep..lue Prediction Screener Map

Hangzhou Tigermed Consulting Overview

Industry: Biotechnology & Medical Research

Sector: Healthcare

Hangzhou Tigermed Consulting is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Hangzhou Tigermed Consulting in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Hangzhou Tigermed Consulting Competitors

Hangzhou Tigermed Consulting operates in the Biotechnology & Medical Research industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Hangzhou Tigermed Consulting

US$38.02

US$58.0b

-5.33%

43.20%